Geographic Atrophy Long-Terms Outcomes Study

Clinical trial NCT06499571 · COMPLETED

Trial details

NCT number: NCT06499571
Sponsor: Apellis Pharmaceuticals, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Geographic Atrophy

Start date: 2022-09-01
Primary completion: 2023-07-31
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.